recently, the price of Chinese patent medicine has risen China Business Daily reporter learned that Guangyuyuan Chinese Herbal Medicine Co.Ltd(600771) , Beijing Tongrentang Co.Ltd(600085) , Yunnan Baiyao Group Co.Ltd(000538) , Jiuzhitang Co.Ltd(000989) and other enterprises have announced price increases for some products. What are the “push hands” behind the price rise, and whether the price rise of products will always be concernedp align=”center” style=”text-align:left;”> rise in the price of Chinese patent medicine Lbx Pharmacy Chain Joint Stock Company(603883) bluntly “you have to eat when you should”
It is understood that on April 1, Guangyuyuan Chinese Herbal Medicine Co.Ltd(600771) implemented a new price for its high-quality Angong Niuhuang Pill: Angong Niuhuang Pill (double natural iron box 3G pill) × 1 pill / box × 6) 5880 yuan / box; Angong Niuhuang Pill (double natural wooden box 3G pill) × 1 pill / box × 2) 3360 yuan / box; Angong Niuhuang Pill (double natural wooden box 3G pill) × 1 pill / box × 6 boxes) 10080 yuan / box The rising prices of Chinese herbal medicines such as musk and musk were mainly caused by the rising prices of Chinese herbal medicine dealers Beijing Tongrentang Co.Ltd(600085) also told reporters that the reason why the company raised the sales price of Angong Niuhuang Pill (3G pill / box) from 780 yuan to 860 yuan was that the price of natural Niuhuang and musk increased .
in addition to Guangyuyuan Chinese Herbal Medicine Co.Ltd(600771) , Beijing Tongrentang Co.Ltd(600085) , Jiuzhitang Co.Ltd(000989) , Yunnan Baiyao Group Co.Ltd(000538) , Chongqing Taiji Industry (Group) Co.Ltd(600129) , China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) among them, Jiuzhitang Co.Ltd(000989) raised the supply price or suggested retail price of 21 Chinese patent medicines including Angong Niuhuang Pill, Liuwei Dihuang pill and Xiaoyao Pill, with a price adjustment range of 6% – 30% The ex factory price of Yunnan Baiyao Group Co.Ltd(000538) (powder) products of Yunnan Baiyao Group Co.Ltd(000538) , Huoxiang Zhengqi oral liquid of Chongqing Taiji Industry (Group) Co.Ltd(600129) and Angong Niuhuang Pill of China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) have increased.
will the increase in the price of Chinese patent medicine affect the sales volume The salesperson of Beijing Tongrentang Co.Ltd(600085) pharmacy told the reporter of China Business Daily that it did not have much impact, the loyalty of old customers was high, and they also understood the price rise Jiuzhitang Co.Ltd(000989) the salesperson said that the increase of ex factory price will affect the retail price, but the stores will also do activities, and the sales volume is similar to that in the past.
Consumers also admitted to reporters that they prepare Angong Niuhuang pills for the elderly at home every year, and they often prepare Xiaoyao pills, “although the price rises, we still have to eat.”
the “push” behind the price increase is not just the rising price of traditional Chinese Medicine
from the current situation, it can be seen that one of the main reasons for the rise in the price of proprietary Chinese medicine is the increase in the price of traditional Chinese medicine Wang Wen (a pseudonym), the person in charge of a pharmaceutical enterprise in Hebei Province, told the China Business Daily that taking Angong Niuhuang Pill as an example, the formation rate of natural bezoar (stones naturally grown by cattle) is low because cattle have little chance of hepatolithiasis. At present, natural bezoar is collected in a more traditional way, that is, in a cattle farm. The quantity of bezoar collected in this way is very uncertain. He said that the price of natural bezoar is about 5 Shenzhen Zhenye(Group)Co.Ltd(000006) 00000 yuan per kilogram. “One gram of natural bezoar is more expensive than gold.”
In addition, Wang Wen said that musk, another traditional Chinese medicine of Angong Niuhuang Pill, is produced in the belly button of musk deer. Now a certain amount of musk can be obtained by artificially raising musk deer, but an adult musk deer can only secrete 15-20 grams of musk every year. “The output of these precious Chinese herbal medicines is very small, but consumers’ demand for products is increasing. When the supply of Chinese herbal medicines is in short supply, the price will also increase.”
and the price rise of some Chinese herbal medicines is due to the decrease in the production of producing areas last year Wang Wen introduced to the reporter of China Business Daily that the planting of traditional Chinese medicine was greatly affected by the weather, and more rainfall in some planting areas led to a reduction in production, while the market supply decreased accordingly. “For example, the main components of Liuwei Dihuang pill, such as Rehmannia glutinosa and peony bark, decreased in varying degrees last year.”
in addition, the improvement of national requirements for the quality of traditional Chinese medicine is also increasing the cost of products Anguo Chinese herbal medicine wholesale trading market merchant Zhang Wenhai told China Business Daily that due to the implementation of the 2020 edition of the Pharmacopoeia of the people’s Republic of China, enterprises have improved the quality requirements of Chinese herbal medicine, such as Chinese wolfberry. Many pharmaceutical enterprises must have a “white tip” at the tail of the newly picked Chinese wolfberry in Ningxia in June every year; Another example is Astragalus membranaceus. Pharmaceutical enterprises have strict requirements for the pesticide residue and heavy metal content of the purchased Astragalus membranaceus, and all those that do not meet the standards should be returned. “In the past, farmers planted medicinal materials and could weed with pesticides. Now, in order to meet the standard, they can only weed manually, which increases the planting cost.”
the cost of Chinese herbal medicines in the process of processing and storage is also rising accordingly a staff from the quality inspection department of a listed traditional Chinese medicine enterprise told the China Business Daily that the purchased medicinal materials need to be screened layer by layer and can be made into finished products through multiple processes. In this process, labor costs, storage costs and environmental protection costs are risingp align=”center” style=”text-align:left;”> multiple cost increases will the price of Chinese patent medicine rise all the time
A relevant analyst told the China Business Daily that in recent years, the price of Angong Niuhuang Pill has been at a high level. At present, the number of pharmaceutical enterprises that can make Angong Niuhuang Pill with “dual nature” (i.e. natural bezoar and natural musk) is limited, the product may be difficult to reduce the cost in a short time due to its rarity
Li Ye, an expert in the pharmaceutical industry, said that Angong Niuhuang Pill is not a common drug for Lbx Pharmacy Chain Joint Stock Company(603883) more Lbx Pharmacy Chain Joint Stock Company(603883) frequently used proprietary Chinese medicines will remain stable after the price increases he believes that, on the one hand, the prices of many Chinese herbal medicines are cyclical and will return to stability after being digested by the market; On the other hand, enterprises, growers and dealers in the industry will adapt to the industry standards after a certain period of time, and there is little possibility that the cost will rise again.
it is understood that relevant departments have also begun to collect Chinese patent medicines to reduce drug prices in January this year, the bid opening of 19 provinces (autonomous regions and municipalities) alliance centralized procurement of Chinese patent medicines led by Hubei Province, 97 enterprises and 111 products were selected, with a winning rate of 62%, an average decline of 42.27% and a maximum decline of 82.63%.
It is reported that this centralized procurement is the first centralized procurement of Chinese patent medicine alliance in China. A total of 157 enterprises and 182 products participated in the quotation, and the procurement scale is nearly 10 billion yuan. Li Ye believes that the centralized procurement of Chinese patent medicines in volume has opened a good start for the centralized procurement of Chinese patent medicines in the future, which is conducive to patients’ access to high-quality and cost-effective Chinese patent medicines, as well as the development of industry standardization and standardization of Chinese herbal medicines.
